Clinical Trials
Intervention Treatment
CRESCENDO: Rimonabant vs. placebo for reducing the
risk of myocardial infarction, stroke, or cardiovascular death
in patients with abdominal obesity.
IMPROVE IT: To evaluate the clinical benefit of
Ezetimibe/Simvastatin combination compared with Simvastatin in
stabilized acute coronary syndrome subjects.
PFO Access: Documented PFO who have experienced at
least two cryptogentic strokes.
Information on clinical research trials conducted by our faculty is
listed below (listed alphabetically by trial acronym.)
Note: For additional information on any trial please
contact the Nurse Coordinator as listed.
|
